Tryptophan Hydroxylase-1 Gene Variants Associated with Schizophrenia

Biological Psychiatry

Volumn 60, Issue 6, 2006, Pages 563-569

  Zaboli, Ghazal ^a   Jönsson, Erik G ^a   Gizatullin, Rinat ^a   Åsberg, Marie ^a   Leopardi, Rosario ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gene variant; haplotype; linkage disequilibrium; schizophrenia; SNP; tryptophan hydroxylase

Indexed keywords

TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EUROPE; FEMALE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS; MIDDLE AGED; PROMOTER REGIONS (GENETICS); PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TRYPTOPHAN HYDROXYLASE; VARIATION (GENETICS);

EID: 33748748127     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.033     Document Type: Article

References (59)

1. Aghajanian G.K. Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain. NIDA Res Monogr 146 (1994) 183-202
2. American Psychiatric Association. Diagnostic and Statistical manual of mental disorders. 3rd Edition, revised (1987), American Psychiatric Association, Washington, DC
3. Arango V., Huang Y.Y., Underwood M.D., and Mann J.J. Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res 37 (2003) 375-386
4. Breier A. Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 14 (1995) 187-202
5. Cardon L.R., and Bell J.I. Association study designs for complex diseases. Nat Rev Genet 2 (2001) 91-99
6. Chao H.M., and Richardson M.A. Aromatic amino acid hydroxylase genes and schizophrenia. Am J Med Genet 114 (2002) 626-630
7. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 18 (1993) 1-32
8. Chotai J., Serretti A., and Lorenzi C. Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders. Neuropsychobiology 51 (2005) 3-9
9. Clark A.G. The role of haplotypes in candidate gene studies. Genet Epidemiol 27 (2004) 321-333
10. Cooper J.R., and Melcer I. The enzymic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin. J Pharmacol Exp Ther 132 (1961) 265-268
11. Courtet P., Jollant F., Castelnau D., Buresi C., and Malafosse A. Suicidal behavior: relationship between phenotype and serotonergic genotype. Am J Med Genet C Semin Med Genet 133 (2005) 25-33
12. Craddock N., O'Donovan M.C., and Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 42 (2005) 193-204
13. Craig S.P., Boularand S., Darmon M.C., Mallet J., and Craig I.W. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3----p14 by in situ hybridization. Cytogenet Cell Genet 56 (1991) 157-159
14. De Luca V., Voineskos D., Wong G.W., Shinkai T., Rothe C., Strauss J., et al. Promoter polymorphism of second tryptophan hydroxylase isoform (TPH2) in schizophrenia and suicidality. Psychiatry Res 134 (2005) 195-198
15. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
16. Geijer T., Frisch A., Persson M.L., Wasserman D., Rockah R., Michaelovsky E., et al. Search for association between suicide attempt and serotonergic polymorphisms. Psychiatr Genet 10 (2000) 19-26
17. Gizatullin R., Zaboli G., Jonsson E.G., Asberg M., and Leopardi R. Haplotype Analysis Reveals Tryptophan Hydroxylase (TPH) 1 Gene Variants Associated with Major Depression. Biol Psychiatry 59 (2006) 295-300
18. Graeff F.G. Role of 5-HT in defensive behavior and anxiety. Rev Neurosci 4 (1993) 181-211
19. Gurevich E.V., and Joyce J.N. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study. Biol Psychiatry 42 (1997) 529-545
20. Gustavsson J.P., Nothen M.M., Jonsson E.G., Neidt H., Forslund K., Rylander G., et al. No association between serotonin transporter gene polymorphisms and personality traits. Am J Med Genet 88 (1999) 430-436
21. Hoehe M.R. Haplotypes and the systematic analysis of genetic variation in genes and genomes. Pharmacogenomics 4 (2003) 547-570
22. Hong C.J., Tsai S.J., and Wang Y.C. Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Schizophr Res 49 (2001) 59-63
23. Hughes C., Kumari V., Soni W., Das M., Binneman B., Drozd S., et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr Res 59 (2003) 137-146
24. Iqbal N., and van Praag H.M. The role of serotonin in schizophrenia. Eur Neuropsychopharmacol 5 Suppl (1995) 11-23
25. Jonsson E.G., Goldman D., Spurlock G., Gustavsson J.P., Nielsen D.A., Linnoila M., et al. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 247 (1997) 297-302
26. Jonsson E.G., Norton N., Forslund K., Mattila-Evenden M., Rylander G., Asberg M., et al. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr Res 61 (2003) 31-37
27. Joyce J.N., Shane A., Lexow N., Winokur A., Casanova M.F., and Kleinman J.E. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8 (1993) 315-336
28. Judson R., Stephens J.C., and Windemuth A. The predictive power of haplotypes in clinical response. Pharmacogenomics 1 (2000) 15-26
29. Lieberman J.A., Mailman R.B., Duncan G., Sikich L., Chakos M., Nichols D.E., et al. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry 44 (1998) 1099-1117
30. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 (2003) 177-182
31. Mann J.J., Malone K.M., Nielsen D.A., Goldman D., Erdos J., and Gelernter J. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry 154 (1997) 1451-1453
32. Meltzer H.Y. Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci 3 (1995) 64-75
33. Meltzer H.Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21 (1999) 106S-115S
34. Mowry B.J., and Nancarrow D.J. Molecular genetics of schizophrenia. Clin Exp Pharmacol Physiol 28 (2001) 66-69
35. Nielsen D.A., Jenkins G.L., Stefanisko K.M., Jefferson K.K., and Goldman D. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res 45 (1997) 145-148
36. Nielsen D.A., Virkkunen M., Lappalainen J., Eggert M., Brown G.L., Long J.C., et al. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry 55 (1998) 593-602
37. Nolan K.A., Volavka J., Lachman H.M., and Saito T. An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder. Psychiatr Genet 10 (2000) 109-115
38. O'Donovan M.C., Williams N.M., and Owen M.J. Recent advances in the genetics of schizophrenia. Hum Mol Genet 12 (2003) R125-R133 Spec No 2
39. Paik I., Toh K., Kim J., and Lee C. TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population. Hum Hered 50 (2000) 365-369
40. Prasad S., Semwal P., Deshpande S., Bhatia T., Nimgaonkar V.L., and Thelma B.K. Molecular genetics of schizophrenia: past, present and future. J Biosci 27 (2002) 35-52
41. Riedel W.J., Sobczak S., and Schmitt J.A. Tryptophan modulation and cognition. Adv Exp Med Biol 527 (2003) 207-213
42. Rotondo A., Schuebel K., Bergen A., Aragon R., Virkkunen M., Linnoila M., et al. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry 4 (1999) 360-368
43. Rund B.R., Melle I., Friis S., Larsen T.K., Midboe L.J., Opjordsmoen S., et al. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry 161 (2004) 466-472
44. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124 (1996) 57-73
45. Sekizawa T., Iwata Y., Nakamura K., Matsumoto H., Suzuki A., Suzuki K., et al. Childhood-onset schizophrenia and tryptophan hydroxylase gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 128 (2004) 24-26
46. Semwal P., Prasad S., Bhatia T., Deshpande S.N., Wood J., Nimgaonkar V.L., et al. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Mol Psychiatry 6 (2001) 220-224
47. Semwal P., Prasad S., Varma P.G., Bhagwat A.M., Deshpande S.N., and Thelma B.K. Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study. J Genet 81 (2002) 65-71
48. Serretti A., Lilli R., Lorenzi C., Lattuada E., Cusin C., and Smeraldi E. Tryptophan hydroxylase gene and major psychoses. Psychiatry Res 103 (2001) 79-86
49. Shinkai T., Ohmori O., Suzuki T., Kojima H., Hori H., Terao T., et al. Polymorphisms of tryptophan hydroxylase gene and the symptomatology of schizophrenia: an association study. Psychiatr Genet 10 (2000) 165-171
50. Skodol A.E., Siever L.J., Livesley W.J., Gunderson J.G., Pfohl B., and Widiger T.A. The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry 51 (2002) 951-963
51. Sodhi M.S., and Sanders-Bush E. Serotonin and brain development. Int Rev Neurobiol 59 (2004) 111-174
52. Spitzer R.L., Williams J.B., Gibbon M., and First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49 (1992) 624-629
53. Sumiyoshi T., Stockmeier C.A., Overholser J.C., Dilley G.E., and Meltzer H.Y. Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 708 (1996) 209-214
54. Walther D.J., and Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66 (2003) 1673-1680
55. Westenberg H.G. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?. J Affect Disord 40 (1996) 85-93
56. Whitaker-Azmitia P.M., Borella A., and Raio N. Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2. A new animal model of schizophrenia?. Neuropsychopharmacology 12 (1995) 269-272
57. Whitaker-Azmitia P.M., Shemer A.V., Caruso J., Molino L., and Azmitia E.C. Role of high affinity serotonin receptors in neuronal growth. Ann N Y Acad Sci 600 (1990) 315-330
58. Zill P., Baghai T.C., Zwanzger P., Schule C., Eser D., Rupprecht R., et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry 9 (2004) 1030-1036
59. Zill P., Buttner A., Eisenmenger W., Bondy B., and Ackenheil M. Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur Neuropsychopharmacol 14 (2004) 282-284